Easing the Burden for Women

Concure Oncology In The News

Mary Washington Healthcare First In Washington D.C. Metro Area To Offer Breast Microseed Treatment®

The Mary Washington Healthcare (MWHC) Regional Cancer Center is one of only six sites in the U.S. and the first in the Washington D.C. metro area to offer the most advanced radiation therapy for early stage breast cancer.

Read the full article

Watch the video

Breast Microseed Treatment® Featured in North Maple Valley Living

Each October during breast cancer awareness month, women are reminded to schedule their mammograms…and they cringe.  We get it.  Mammograms aren’t much fun.  But isn’t your life worth more than a few moments of discomfort?
 
Read the full article

Press Release & Video: Breast Microseed Treatment® now available in MS at Greenwood Leflore Hospital

Greenwood, MS – (November 13, 2017) – The Cancer Center at Greenwood Leflore Hospital announced that the Radiation Oncology department is the only site in Mississippi and one of only five sites in the U.S. to offer the latest in radiation therapy for early stage breast cancer: Breast Microseed Treatment®.

Read the full press release 
 
Watch the video

Concure Oncology Featured In Mercer Island Living Magazine

Being diagnosed with breast cancer is scary enough without having to worry about treatment options. Concure Oncology is working to change that with Breast Microseed Treatment®, an incredible new treatment option for early-stage breast cancer.

Read the full article here

Press Release - Groundbreaking Treatment for Early-Stage Breast Cancer Now Offered at Bon Secours Cancer Institute at DePaul

Breast Microseed Treatment® offers women on-time, one-hour outpatient cancer treatment.  Bon Secours Cancer Institute at DePaul announced today that the Radiation Oncology department is now one of only three sites in the U.S., and the only in the southeast, to offer the latest in radiation therapy for early stage breast cancer: Breast Microseed Treatment.

Read the full press release.

Press Release - Concure Oncology® Announces the Appointment of Former Group Health President and CEO Scott Armstrong to Board

Concure Oncology, parent company of Breast Microseed Treatment®, announces the appointment of Scott Armstrong, former President and CEO of Group Health Cooperative, to its Board of Directors.

Read the full press release

Breast Microseed Treatment® featured on Health Matters, Fox Sports Radio

Press Release - Concure Oncology® Announces New Appointment to Board of Directors

Concure Oncology, the parent company of Breast Microseed Treatment®, announces the appointment of Mona Lee Locke, former First Lady of Washington State and former Executive Director of Susan G. Komen Foundation, Puget Sound, to its Board of Directors.

Read the full press release

Breast Microseed Treatment® featured on “Breast Friends Cancer Support Radio”

Hear from a breast surgeon and patient of Breast Microseed Treatment on the VoiceAmerica Health and Wellness Channel.

A “Game-Changer” for Breast Cancer

Concure Oncology interview with 4Word. 

Read the interview here

Concure Oncology Featured on KOMO 4 News "Healthworks"

A Seattle woman is the first in the country to undergo a new breast cancer treatment. She called it "a no brainer." Her doctor called it historic.

Watch the video/read the article on KOMO News

Press Release - One Time, One Hour. Concure Oncology launches single-time, one-hour radiation treatment for early-stage breast cancer

Breast Microseed Treatment significantly lessens the side effects, frequency and duration of radiation treatment following surgery for early-stage breast cancer. Currently, women who are diagnosed with early-stage breast cancer are faced with the choice of undergoing mastectomies, or up to 30 radiation treatment sessions, taking them away from home or work for extended periods.

Read the full press release.

Puget Sound Business Journal - Concure Oncology teams up with Swedish Cancer Institute for new breast cancer treatment

Mercer Island startup Concure Oncology has introduced a new procedure for treating early-stage breast cancer, with the first U.S. patient receiving the procedure at the Swedish Cancer Institute location on First Hill.

Read the full article here

Concure Oncology Featured on King 5 TV's "New Day Northwest"

On New Day Northwest, Dr. Karen Hendershott, Surgical Specialist in Breast Surgery at Swedish Medical Center, and Suzanne Hansen, Director of Clinical Affairs and Nurse Educator at Concure Oncology, outlined how Breast Microseed Treatment was developed, how it works, and who would benefit most from the treatment.

Watch the video on King 5 

GeekWire - Concure Oncology raises money for new radiation therapy Breast Microseed Treatment

There’s a new treatment option for women diagnosed with early-stage breast cancer. It’s called Breast Microseed Treatment and is a targeted radiation therapy that is being introduced in the U.S. by a Mercer Island, Wash.-based healthcare startup, Concure Oncology. The treatment is now available at Seattle’s Swedish Medical Center.

Read the full article here

Breast Microseed Treatment featured on iHeartRadio's Treatment SOS Program

Breast Microseed Treatment is showcased on the Joni Aldrich show "Supporter of Survival" (SOS).

Listen to the program here.

Concure Oncology®

Dedicated to helping you put cancer behind you so you can get back to your life faster, with the peace of mind that comes from following the appropriate breast cancer treatment to help prevent a recurrence.

 
Kevin Kelley
Chief Executive Officer
 
Jason Dyer
Vice President, U.S. Sales

Learn More | Meet the Team

Contact Us

Concure Oncology
3010 77th Ave. SE, Suite 206
Mercer Island, WA 98040